Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital

被引:57
|
作者
Miranda-Zapico, Ilargi [1 ]
Eraso, Elena [1 ]
Luis Hernandez-Almaraz, Jose [2 ]
Monica Lopez-Soria, Leyre [2 ]
Javier Carrillo-Munoz, Alfonso [3 ]
Manuel Hernandez-Molina, Juan [4 ]
Quindos, Guillermo [1 ]
机构
[1] Univ Pais Vasco Eskual Herriko Unibertsitatea, Lab Micol Med, Dept Inmunol Microbiol & Parasitol, Fac Med & Odontol, Bilbao, Spain
[2] Hosp Univ Cruces, Microbiol Serv, Baracaldo, Spain
[3] ACIA Microbiol, Barcelona, Spain
[4] Hosp Carlos Haya, Microbiol Serv, Malaga, Spain
关键词
antifungal susceptibility; C; bracarensis; glabrata; metapsilosis; nivariensis; orthopsilosis; parapsilosis; Spain; MOLECULAR DIFFERENTIATION; STREAM INFECTIONS; SP-NOV; ORTHOPSILOSIS; METAPSILOSIS; IDENTIFICATION; SURVEILLANCE; VORICONAZOLE; NIVARIENSIS; BRACARENSIS;
D O I
10.1093/jac/dkr298
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: There is scarce information on the clinical relevance and antifungal susceptibility of Candida bracarensis, Candida nivariensis, Candida orthopsilosis and Candida metapsilosis. The objective of this study was to assess the prevalence and in vitro antifungal susceptibility of these cryptic species among 173 blood isolates previously identified as Candida glabrata or Candida parapsilosis at the Hospital of Cruces (Barakaldo, Spain). The survey was extended to 518 clinical isolates from the culture collection of the Universidad del Pais Vasco-Euskal Herriko Unibertsitatea (UPV-EHU; Bilbao, Spain). Methods: In vitro susceptibilities to 5-fluorocytosine, amphotericin B, anidulafungin, caspofungin, fluconazole, itraconazole, micafungin, posaconazole and voriconazole were tested. Results: All isolates of C. glabrata were identified as C. glabrata sensu stricto. Inside the C. parapsilosis complex, 2.4% of isolates from the Hospital of Cruces and 5.8% from the UPV-EHU were C. metapsilosis or C. orthopsilosis. Of 457 isolates, 435 (95.19%) were C. parapsilosis sensu stricto, 11 (2.41%) C. metapsilosis and 11 (2.41%) C. orthopsilosis. Only seven blood isolates were C. metapsilosis (0.44%) or C. orthopsilosis (1.09%). These cryptic species were also isolated from other relevant clinical specimens. Four C. parapsilosis sensu stricto (5.6%) were susceptible dose-dependent, and one was resistant to both fluconazole and voriconazole (1.4%). Moreover, 19 isolates of C. parapsilosis sensu stricto (26.4%) were intermediately susceptible to itraconazole and higher concentrations of echinocandins were needed to inhibit this species. Most C. orthopsilosis and C. metapsilosis were susceptible to all antifungal agents tested, but one otic isolate of C. metapsilosis was resistant to fluconazole and 5-fluorocytosine. Conclusions: C. metapsilosis and C. orthopsilosis are associated with human disease and show a different antifungal susceptibility profile compared with C. parapsilosis sensu stricto.
引用
收藏
页码:2315 / 2322
页数:8
相关论文
共 50 条
  • [21] Five years antifungal susceptibility profiles of Candida isolates from blood in tertiary care hospital
    Worasilchai, N.
    Atikanbodee, D.
    Ounjai, S.
    Ritkumrop, P.
    Thayidathara, P.
    Chindamporn, A.
    MYCOSES, 2012, 55 : 109 - 110
  • [22] Urinary Isolates and Antifungal Susceptibility Pattern of Candida species Isolated from Patients in Tertiary Care
    Samyuktha, A. Arasi
    Illamani, V
    Saikumar, Chitralekha
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (25A) : 48 - 56
  • [23] Species Identification of Candida Isolates in Various Clinical Specimens with Their Antifungal Susceptibility Patterns
    Dharwad, Shivanand
    Dominic, Saldanha R. M.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2011, 5 (06) : 1177 - 1181
  • [24] Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015
    Pharkjaksu, Sujiraphong
    Chongtrakool, Piriyaporn
    Suwannakarn, Kamol
    Ngamskulrungroj, Popchai
    MEDICAL MYCOLOGY, 2018, 56 (04) : 426 - 433
  • [25] Presence of Candida bracarensis, Candida nivariensis, Candida orthopsilosis, and Candida metapsilosis among blood isolates from the Spanish tertiary hospital of Cruces, Barakaldo
    Miranda-Zapico, I.
    Eraso, E.
    Hernandez-Almaraz, J. L.
    Lopez-Soria, L.
    Carrillo-Munoz, A. J.
    Hernandez-Molina, J. M.
    Quindos, G.
    MYCOSES, 2011, 54 : 148 - 148
  • [26] Identification of Candida Species from Clinical Isolates and Their Antifungal Susceptibility Pattern
    Deepthi, K. N.
    Menon, Ardra R.
    Nair, K. Prithi
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2020, 9 (24): : 1813 - 1817
  • [27] Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina
    Eugenia Morales-Lopez, Soraya
    Taverna, Constanza G.
    Eugenia Bosco-Borgeat, Maria
    Maldonado, Ivana
    Vivot, Walter
    Szusz, Wanda
    Garcia-Effron, Guillermo
    Cordoba, Susana B.
    MYCOPATHOLOGIA, 2016, 181 (11-12) : 871 - 878
  • [28] Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina
    Soraya Eugenia Morales-López
    Constanza G. Taverna
    María Eugenia Bosco-Borgeat
    Ivana Maldonado
    Walter Vivot
    Wanda Szusz
    Guillermo Garcia-Effron
    Susana B. Córdoba
    Mycopathologia, 2016, 181 : 871 - 878
  • [29] Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel
    Samra, Z
    Yardeni, M
    Peled, N
    Bishara, J
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (09) : 592 - 595
  • [30] Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel
    Z. Samra
    M. Yardeni
    N. Peled
    J. Bishara
    European Journal of Clinical Microbiology and Infectious Diseases, 2005, 24 : 592 - 595